within BCGN Homolog Protein |
20-abx262900 |
Abbexa |
-
EUR 393.60
-
EUR 7676.40
-
EUR 276.00
|
|
|
Human IgG antibody Laboratories manufactures the rbd antigen within spike protein reagents distributed by Genprice. The Rbd Antigen Within Spike Protein reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Antigen. Other Rbd products are available in stock. Specificity: Rbd Category: Antigen Group: Within Spike
Human SARS-CoV-2 Spike Protein S1 IgG (S1-IgG) ELISA Kit |
Sunlong |
96 Tests |
EUR 468 |
|
Within Spike information
SARS-CoV-2 Spike Glycoprotein (S1) RBD, His-Tag (HEK293) |
REC31882-500 |
The Native Antigen Company |
0.5 |
EUR 1599.79 |
Description: SARS-CoV-2 Spike protein receptor binding domain (RBD) produced in HEK293 cells. The protein was purified from culture supernatant by immobilised metal affinity chromatography |
GENLISA SARS-CoV-2 (2019-nCoV) Spike RBD Antigen Quantitative ELISA |
KBVH015-34 |
Krishgen |
1 x 96 wells |
EUR 979 |
SARS Spike RBD Recombinant Protein |
10-211 |
ProSci |
0.1 mg |
EUR 651.3 |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
SARS-CoV-2 (N501Y Mutant) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) |
REC31946-100 |
The Native Antigen Company |
0.1 |
EUR 419.73 |
Description: SARS-CoV-2 Spike S1 RBD (AA1-223), carrying the N501Y amino acid change. This change is present in all three major global SARS-CoV-2 variants: B.1.1.7, B.1.1.28 and B.1.351. The protein was produced in HEK293 cells and purified from culture supernanant. |
SARS-CoV-2 (N501Y Mutant) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) |
REC31946-500 |
The Native Antigen Company |
0.5 |
EUR 1599.79 |
Description: SARS-CoV-2 Spike S1 RBD (AA1-223), carrying the N501Y amino acid change. This change is present in all three major global SARS-CoV-2 variants: B.1.1.7, B.1.1.28 and B.1.351. The protein was produced in HEK293 cells and purified from culture supernanant. |
SARS-CoV-2 Spike Glycoprotein (S1) RBD, His-Tag (HEK293): Biotin Conjugate |
REC31882-Biotin-100 |
The Native Antigen Company |
0.1 |
EUR 501.38 |
Description: SARS-CoV-2 Spike protein receptor binding domain (RBD) produced in HEK293 cells. The protein was purified from culture supernatant by immobilised metal affinity chromatography and conjugated to biotin. |
SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) |
REC32007-100 |
The Native Antigen Company |
0.1 |
EUR 419.73 |
Description: Recombinant SARS-CoV-2 Omicron variant Spike receptor binding domain protein. Relative to Wuhan-Hu-1 this protein has following amino acid changes: G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H. |
SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) |
REC32007-500 |
The Native Antigen Company |
0.5 |
EUR 1599.79 |
Description: Recombinant SARS-CoV-2 Omicron variant Spike receptor binding domain protein. Relative to Wuhan-Hu-1 this protein has following amino acid changes: G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H. |
SARS-CoV-2 (B.1.617.1: E484Q, L452R) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) |
REC31971-100 |
The Native Antigen Company |
0.1 |
EUR 419.73 |
Description: SARS-CoV-2 B.1.617.1 (Kerala variant) receptor binding domain (E484Q, L452R amino acid changes relative to Wuhan-Hu-1). |
SARS-CoV-2 (B.1.617.1: E484Q, L452R) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) |
REC31971-500 |
The Native Antigen Company |
0.5 |
EUR 1599.79 |
Description: SARS-CoV-2 B.1.617.1 (Kerala variant) receptor binding domain (E484Q, L452R amino acid changes relative to Wuhan-Hu-1). |
SARS-CoV-2 (B.1.617.2; L452R, T478K) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) |
REC31974-100 |
The Native Antigen Company |
0.1 |
EUR 419.73 |
Description: SARS-CoV-2 receptor binding domain with the two amino acid changes L452R and T478K relative to Wuhan-Hu-1 full length Spike protein. |
SARS-CoV-2 (B.1.617.2; L452R, T478K) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) |
REC31974-500 |
The Native Antigen Company |
0.5 |
EUR 1599.79 |
Description: SARS-CoV-2 receptor binding domain with the two amino acid changes L452R and T478K relative to Wuhan-Hu-1 full length Spike protein. |
Recombinant SARS-CoV-2 Spike RBD Protein with mFc Tag |
E80011-1 |
EpiGentek |
100 ul |
EUR 588.5 |
Recombinant SARS-CoV-2 Spike RBD Protein with His-Tag |
E80000-1 |
EpiGentek |
100 ul |
EUR 518.1 |
Recombinant SARS-CoV-2 Spike RBD Protein with His-Tag |
E80015-1 |
EpiGentek |
100 ul |
EUR 695.2 |
SARS-CoV-2 (501Y.V2: K417N, E484K, N501Y) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) |
REC31945-100 |
The Native Antigen Company |
0.1 |
EUR 419.73 |
Description: SARS-CoV-2 Spike receptor binding domain RBD. Contains amino acid changes K417N, E484K, N501Y relative to Wuhan Hu-1. The protein was produced in HEK293 cells and purified from culture supernatant. |
SARS-CoV-2 (501Y.V2: K417N, E484K, N501Y) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) |
REC31945-500 |
The Native Antigen Company |
0.5 |
EUR 1599.79 |
Description: SARS-CoV-2 Spike receptor binding domain RBD. Contains amino acid changes K417N, E484K, N501Y relative to Wuhan Hu-1. The protein was produced in HEK293 cells and purified from culture supernatant. |